CVR 24257584Public limited company (A/S)Ikke-finansielle holdingselskaber (642120)Kongebakken 9, 2765 SmørumFounded 13 Aug 1999
OTICON MEDICAL A/S
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about OTICON MEDICAL A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
19
CVR, Aug 2026
Gross profit
28.9M
DKK, annual report 2025
-42.8% on 2024
Result
+33.3M
DKK, annual report 2025
Equity
275M
DKK, annual report 2025
Osseosound International AB100% of capital and votes
Group holding company
Dandex estimate: NACE 642120, controlled by an owner outside CVRRené Jacobus Maria Govaertssince 24 Mar 2026
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 31 Mar 2026
CVR 71186911100% of capital and votesnotified 31 Mar 202626 Nov 2007 to 31 Mar 2026
Founded 13 Aug 1999.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 19 employees, 18 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|
| Employees | 14 | 16 | 16 | 17 | 19 |
| FTE | 14 | 16 | 16 | 15 | 18 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit 28.9M, Operating profit 15.5M, Result for the year 33.3M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 350.6M, Equity 275M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 125,730 | 5,390 | 73,057 | 50,522 | 28,895 |
| Operating profit | +80,481 | +19,350 | +72,199 | +48,622 | +15,535 |
| Result for the year | +70,889 | +33,493 | +75,370 | +61,797 | +33,261 |
| Equity | 496,322 | 99,455 | 175,779 | 234,297 | 274,988 |
| Total assets | 574,854 | 149,102 | 274,746 | 345,632 | 350,604 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
2025: The 2025 report shows 2024 in amounts a thousand times smaller than the 2024 report does, and this filing states its share capital a thousand times smaller than CVR registers it, so it tagged its amounts in the wrong unit. Dandex multiplied them by a thousand.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 25,000,000, cash price 25.00, implied value 75,000,000 | 25.00 | 25,000,000 | 75,000,000 | 3,000,000 | |
| IncreaseCashPaid in 10,000,000, cash price 10.00, implied value 20,000,000 | 10.00 | 10,000,000 | 20,000,000 | 2,000,000 | |
| IncreaseCashPaid in 30,000,000, cash price 60.00, implied value 60,000,000 | 60.00 | 30,000,000 | 60,000,000 | 1,000,000 | |
| DecreasePaid out to the owners, DKK 2,129,000 | None | None | None | 500,000 | |
| FoundingNot read from the announcement | None | None | None | 2,629,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | 17.9% | -93.2% | 1,255.4% | -30.9% | -42.8% |
| EBITDA | Not reportednote 1 | 20,209 | 73,057 | 50,522 | 28,895 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 2 | 0note 3 | 0note 3 | 87,508note 3 | 0note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
26 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 21.05.2026
Bestyrelse:
Fratrådte:
Søren Nielsen, (formand), den 31.03.2026, Stine Brandenhof Rifsdal, den 31.03.2026, René Schneider, den 31.03.2026.
Tiltrådte:
Eric Pepin Lehalleur, den 31.03.2026, Karolin Isberg Jernby, (formand), den 31.03.2026, René Jacobus Maria Govaerts, den 31.03.2026.
Direktion:
Fratrådte:
Stine Brandenhof Rifsdal, (adm. dir), den 24.03.2026.
Tiltrådte:
René Jacobus Maria Govaerts, (adm. dir), den 24.03.2026.
Bestyrelse:
Fratrådte:
Pelle Kristoffer Munk-Poulsen, den 23.06.2023.
Tiltrådte:
Stine Brandenhof Rifsdal, den 23.06.2023.
Direktion:
Fratrådte:
Pelle Kristoffer Munk-Poulsen, den 23.06.2023.
Tiltrådte:
Stine Brandenhof Rifsdal, (adm. dir), den 23.06.2023.
Direktion:
Fratrådte:
Jes Olsen, den 20.09.2022.
Tiltrådte:
Pelle Kristoffer Munk-Poulsen, den 20.09.2022.
Revision:
Fratrådte:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 20.05.2022.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 20.05.2022.
Bestyrelse:
Fratrådte:
Svend Børge Foged Thomsen, den 26.04.2019.
Tiltrådte:
Pelle Kristoffer Munk-Poulsen, den 26.04.2019.
Bestyrelse:
Fratrådte:
Niels Jacobsen (formand), den 03.05.2017, Søren Nielsen, den 03.05.2017.
Tiltrådte:
Søren Nielsen (formand), den 03.05.2017, Svend Børge Foged Thomsen, den 03.05.2017.
CVR-nummer:
24257584.
NAVN:
OTICON MEDICAL A/S.
Adresse: Kongebakken 9, 2765 Smørum.
Kommune: Egedal.
Vedtægter ændret:
18.05.2011.
Kapitalforhøjelse:
kr. 1.000.000,00 indbetalt kontant, kurs 2.500,00.
Kapitalen udgør herefter kr. 3.000.000,00.
Vedtægter ændret:
20.05.2010.
Kapitalforhøjelse:
kr. 1.000.000,00 indbetalt kontant, kurs 1.000,00.
Kapitalen udgør herefter kr. 2.000.000,00.
Selskabet tegnes af bestyrelsens formand alene, af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør, af to direktører i forening eller af den samlede bestyrelse.
Vedtægter ændret:
28.05.2009.
Kapitalforhøjelse:
kr. 500.000,00 indbetalt kontant, kurs 6.000,00.
Kapitalen udgør herefter kr. 1.000.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Per Kokholm Sørensen, den 28.05.2009.
Indtrådt i bestyrelsen:
Finans- og IR-chef Stefan Ingildsen, den 28.05.2009.
Direktion:
Udtrådt af direktionen:
Rene Jacobus Maria Govaerts, den 15.01.2009.
Indtrådt i direktionen:
Direktør Jes Olsen, den 15.01.2009.
Vedtægter ændret:
20.12.2007.
Nyt navn:
OTICON MEDICAL A/S.
Bestyrelse:
Udtrådt af bestyrelsen:
Rasmus Rømeling, den 20.12.2007, Svend Børge Foged Thomsen, den 20.12.2007.
Indtrådt i bestyrelsen:
Søren Nielsen, den 20.12.2007, Per Kokholm Sørensen, den 20.12.2007.
Direktion:
Udtrådt af direktionen:
Svend Børge Foged Thomsen, den 20.12.2007.
Indtrådt i direktionen:
Rene Jacobus Maria Govaerts, den 20.12.2007.
Selskabets tegnes af bestyrelsens formand alene, af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Bestyrelse:
Udtrådt af bestyrelsen:
Kenneth Aaby Sachse, den 15.10.2007.
Indtrådt i bestyrelsen:
Advokat Rasmus Rømeling, den 15.10.2007.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Vedtægter ændret:
19.05.2006.
Vedtægter ændret:
01.11.2005.
Ny adresse:
Kongebakken 9, 2765 Smørum.
Ny kommune:
Ledøje-Smørum.
Vedtægter ændret:
27.05.2005.
Ny adresse:
c/o WILLIAM DEMANT HOLDING A/S, Strandvejen 58, 2900 Hellerup.
Vedtægter ændret:
07.08.2000.
Kapitalnedsættelse besluttet 16.03.2000 er gennemført 07.08.2000.
Kapitalen udgør herefter kr. 500.000,00.
Ny adresse:
Strandvejen 58, 2900 Hellerup.
Ny kommune:
Gentofte.
Kapitalnedsættelse besluttet 16.03.2000 med udbetaling til aktionærer kr. 2.129.000,00 til kurs 100,00.
Vedtægter ændret:
10.02.2000.
Nyt navn:
WDH NR: 2 A/S.
Ny adresse:
Strandvejen 58, 2900 Hellerup.
Ny kommune:
København.
Bestyrelse:
Udtrådt af bestyrelsen:
Ole Christian Hviid, den 10.02.2000, Claus Frydenlund Hansen, den 10.02.2000, Hans Madsen Pedersen, den 10.02.2000.
Indtrådt i bestyrelsen:
Direktør Niels Jakobsen (formand), den 10.02.2000, Finanschef Kenneth Aaby Sachse, den 10.02.2000, Økonomidirektør Svend Børge Foged Thomsen, den 10.02.2000.
Direktion:
Udtrådt af direktionen:
John Kjærsgaard Pedersen, den 10.02.2000.
Indtrådt i direktionen:
Økonomidirektør Svend Børge Foged Thomsen, den 10.02.2000.
Selskabet tegnes af bestyrelsens formand alene, af den administrerende direktør alene, af 3 bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Revision:
Udtrådt af revisionen:
CVR-NR. 10702402 FYNS ERHVERVSREVISION, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 10.02.2000.
Indtrådt i revisionen:
CVR-NR. 24213714 DELOITTE & TOUCHE STATSAUTORISERET REVISIONSAKTIESELSKAB, H.C. Andersens Boulevard 2, 1780 København V, den 10.02.2000.
Stiftelsesdato:
13.08.1999.
Seneste vedtægtsdato:
13.08.1999.
Kapital:
kr. 2.629.000,00.
Indbetalingsmåde:
kontant kr. 2.629.000,00 til kurs 100,00.
Stiftere:
Elektronikmekaniker Leif Madsen Pedersen, den 13.08.1999, John Kjærsgaard Pedersen, den 13.08.1999, Marketingschef Inger Marie Søbye, den 13.08.1999.
Bestyrelse:
Exportchef Ole Christian Hviid (formand), den 13.08.1999, Elektr.lærling Claus Frydenlund Hansen, den 13.08.1999, Udv. Chef Hans Madsen Pedersen, den 13.08.1999.
Direktion:
John Kjærsgaard Pedersen, den 13.08.1999.
Selskabet tegnes af den samlede bestyrelse, eller 2 bestyrelsesmedlemmer og en direktør.
Revision:
REG.NR. A/S162700 FYNS ERHVERVSREVISION, STATSAUTORISERET REVISIONSAKTIESELSKAB, Vestergade 43, 2., 5000 Odense C, den 13.08.1999.
Første regnskabsår:
13.08.1999 - 31.12.1999.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for OTICON MEDICAL A/S:
Have Pro? Sign in.
P-number 1007416667Strandvejen 58, 2900 Hellerup
P-number 1007524133Kongebakken 9, 2765 Smørum
No other current company drawn.
No other current company drawn.
No other current company drawn.